Public Profile

Pharmax Holding Ltd.

Pharmax Holding Ltd., a prominent player in the pharmaceutical industry, is headquartered in Great Britain and operates extensively across Europe and Asia. Founded in the early 2000s, the company has established itself as a leader in the development and distribution of innovative healthcare solutions, focusing on both prescription and over-the-counter products. With a diverse portfolio that includes advanced formulations and unique delivery systems, Pharmax Holding Ltd. stands out for its commitment to quality and efficacy. The company has achieved significant milestones, including regulatory approvals and strategic partnerships that enhance its market presence. Recognised for its dedication to research and development, Pharmax Holding Ltd. continues to drive advancements in patient care, solidifying its position as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does Pharmax Holding Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Pharmax Holding Ltd.'s score of 35 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Let us know if this data was useful to you

Pharmax Holding Ltd.'s reported carbon emissions

Pharmax Holding Ltd., headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their carbon footprint in terms of kg CO2e across Scope 1, 2, or 3 emissions. While the company has not disclosed any climate commitments or initiatives, it is essential for organisations in the pharmaceutical sector to engage in sustainable practices and set measurable targets to mitigate their environmental impact. The absence of data highlights a potential area for improvement in transparency and accountability regarding climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pharmax Holding Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pharmax Holding Ltd. is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pharmax Holding Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers